At a glance
- Originator Pfizer
- Class Antipsychotics
- Mechanism of Action Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 08 Sep 2006 No development reported - Phase-I for Schizophrenia in USA (PO)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 26 Apr 2001 Phase-I clinical trials for Schizophrenia in USA (PO)